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Abstract
Background: To deal with patients suffering from dyspnoea, it is crucial for general practitioners to know the
prevalences of different diseases causing dyspnoea in the respective area and season, the likelihood of avoidable
life-threatening conditions and of worsening or recovery from disease.
Aim: Aim of our project was to conduct a systematic review of symptom-evaluating studies on the prevalence,
aetiology, and prognosis of dyspnoea as presented to GPs in a primary care setting.
Methods: We did a systematic review of symptom-evaluating studies on dyspnoea in primary care. For this we
included all studies investigating the complaint “dyspnoea” as a primary or secondary consulting reason in general
practice. Apart from qualitative studies, all kind of study designs independent from type of data assessment,
outcome measurement or study quality were included. Symptom-evaluating studies from other settings than
primary care and studies which exclusively included children (age <18 years) were excluded from the review.
Studies selecting patients prior to recruitment, e.g. because of an increased probability for a particular diagnosis,
were also excluded.
Results: This systematic review identified 6 symptom evaluating studies on dyspnoea in the primary care setting.
The prevalence of dyspnoea as reason for consultation ranges from 0.87 to 2.59 % in general practice. Among all
dyspnoea patients 2.7 % (CI 2.2–3.3) suffer from pneumonia. Further specification of underlying aetiologies seems
difficult due to the studies’ heterogeneity showing a great variety of probabilities.
Conclusion: There is a great lack of empirical evidence on the prevalence, aetiology and prognosis of dyspnoea in
general practice. This might yield uncertainty in diagnosis and evaluation of dyspnoea in primary care.
Keywords: Dyspnoea, General practice, Primary care, Systematic review, Symptom evaluating study, Prevalence,
Aetiology
Background
Dyspnoea is defined as “a subjective experience of
breathing discomfort that is comprised of qualitatively
distinct sensations that vary in intensity” [1]. The symp-
tom can be caused by a broad spectrum of diseases from
mostly trivial and self-limiting (e.g. common cold, soma-
tisation disorder) to acute life-threatening (e.g. pulmon-
ary embolism) ones.
Clinical decision making has to rely on disease distri-
butions and probabilities of underlying aetiologies and
the expected course of disease, as well as the nature and
pattern of symptoms. To deal adequately with dyspnoea
general practitioners need to know the prevalences of
different diseases causing dyspnoea in the respective age
group, area and season, the likelihood of avoidable life-
threatening conditions and of worsening or recovery
from disease.
There is empirical evidence of the respective probabil-
ities in the secondary care setting: Mockel et al. described
a dyspnoea prevalence of 7.4 % in the emergency depart-
ments [2]. Also, data from the U.S. National Hospital
Ambulatory Medical Care Survey showed a rate of* Correspondence: annika.viniol@staff.uni-marburg.de
1Department of General Practice / Family Medicine, University of Marburg,
Karl-von-Frisch-Str. 4, 35043 Marburg, Germany
Full list of author information is available at the end of the article
© 2015 Viniol et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Viniol et al. BMC Family Practice  (2015) 16:152 
DOI 10.1186/s12875-015-0373-z
8.4 % among 15 to 64 year old emergency patients
[3], leading to a considerably high in-hospital mortal-
ity of 9.4 % [2].
However, access to primary or secondary care differs,
since general practitioners are often the first point of
contact, whereas secondary care physicians are consulted
by those patients who suffer from more severe symp-
toms, who do not recover or in whom general practi-
tioners suspect a more severe underlying cause of
disease. Prevalences and probabilities from secondary
care are not applicable to at the primary care situation.
So far there are no evidence-based algorithms or guide-
lines for the diagnostic work-up of patients presenting
with dyspnoea in general practice. Aim of our project
was to conduct a systematic review of symptom-
evaluating studies on the prevalence, aetiology, and
prognosis of dyspnoea (as main or secondary complaint)
as presented to general practitioners in daily setting.
Methods
Types of studies
This is a systematic review including symptom-evaluating
studies about dyspnoea at general practice. According to
Donner-Banzhoff et al., symptom evaluating studies are
defined as studies examining patients presenting with a
defined symptom in health care settings. They aim to in-
vestigate prevalence/incidence, differential diagnosis and
prognosis for patients presenting with the symptom [4].
Inclusion and exclusion criteria
We included all studies investigating the complaint “dys-
pnoea” as a primary or secondary consulting reason at
general practice. The findings of the studies had to com-
prise data about the incidence or prevalence of dys-
pnoea, a statement about underlying diagnoses and/or
prognosis. Apart from qualitative studies, all kind of
study designs independent from type of data assessment,
outcome measurement or study quality were included.
Symptom-evaluating studies from other settings than
primary care (primary care is defined as the first-contact
care of patients at the health care system which is ac-
cessible at the time of need, continued, comprehensive
and coordinated [5]; secondary care is offered by medical
specialists who usually do not have first contact with pa-
tients at the health care system or only temporally in
emergency cases) and studies which exclusively included
children (age <18 years) were excluded from the review.
Studies selecting patients prior to recruitment, e.g. be-
cause of an increased probability for a particular diagno-
sis, were also excluded.
Search strategy
We did a computer-based search with the PubMed data-
base in May 2012. The following search syntax was used:
The term “dyspnoea” in title or abstract OR the MESH
term “dyspnea” AND the term “general practice” in title
or abstract OR a journal representing our research area
OR the term “general practice” (in affiliation of authors)
OR the MESH terms “family practice”, “physicians, family”
and “primary health care”. All terms were used in various
notations. The entire syntax is available on request from
the authors (Appendix).
Selection of publications
All identified references went to a two step-selection
process. First, we screened titles and abstracts regarding
to the three criteria, “original research article”, “inclusion
of patients because of dyspnoea”, and “primary care set-
ting”. References meeting all criteria were classified as
potential appropriate. In the second step, we analysed
the full texts of the potentially appropriate studies with
respect to inclusion- and exclusion criteria. Every step of
the selection process was done and documented by two
independent review authors (DB, MB). Different ap-
praisals were resolved by discussion between DB und
MB. In cases of persisted diversities, a third author (AV)
was consulted.
Data extraction
We extracted the following descriptive data of the in-
cluded studies: Bibliographic information (author, publi-
cation year, title, journal), country, setting, study design,
inclusion and exclusion criteria, type of recruitment,
study population (age, gender distribution), and study
duration. To answer the first research question (preva-
lence/incidence), we registered the number of patients
with the consultation reason dyspnoea, the number and
type of the population from which the cases descended
from (e.g. number of all practice consultations or all reg-
istered patients in a practice). Furthermore, we extracted
all diagnostic categories and their absolute and relative
frequencies (second question “aetiology”). Finally, every
kind of prognostic outcome was documented (third re-
search question).
Quality assessment
Until now, there is no published standardized and
accepted quality or reporting guideline for studies of
symptoms. In accordance to Donner-Banzhoff et al.
[4], our research group has developed criteria to
query essential quality characteristics for studies of
symptoms. A validation study is ongoing. Independ-
ent of the particular research question, all included
studies underwent quality assessment regarding the
criteria of Table 4.
Viniol et al. BMC Family Practice  (2015) 16:152 Page 2 of 11
Data analysis
We did the meta-analysis with the random effects model
and calculated confidence intervals to show the preci-
sion of the mean [6]. Since our review includes studies
with various study sizes, we used tau2 and I2 for quantify-
ing heterogeneity. We approximately estimated the 95 %
prediction interval using [expit(PE - 2*tau); expit(PE +
2*tau)], where prediction interval is the random effects
pooled estimate of the proportion on the logit scale and
expit is the inverse logit function. We used the logit trans-
formation because the included studies of our review
mostly contain proportions less than 0.2 or more than
0.8 [7]. The prediction interval describes the distribu-
tion of the true effect size of the included studies and
is an estimate of an interval in which the true effect
size (e.g. prevalence of a symptom) of a future study
will fall with a probability of 95 % [8]. While the con-
fidence interval quantifies the uncertainty in the esti-
mation of the true effect size, the prediction interval
reflects the between study heterogeneity. The fact that
the values of the prediction intervals are equal to the
scale of the original results simplifies the clinical in-
terpretation and makes it more ostensive. We did no
data pooling in cases where prediction intervals were
broader than 10 %.
Data analysis was done with the statistical program R
2.14.0 (R Foundation for statistical analysis, Vienna,
Austria). We used the R package “meta: Meta-Analysis
with R” [9]. Confidence intervals of frequencies were cal-
culated as exact binomial confidence intervals according
to Clopper Pearson.
Results
Search results and study selection
We identified 1915 references via the computer-based
search in PubMed. After title and abstract screening,
117 studies underwent full text analysis. Thereby, six
studies fulfilled the inclusion criteria [10–15]. During
the full text analysis, we excluded the following stud-
ies for the following reasons: not primary care (26
publications); inadaequate study design/population
(five publications); pre-selected study population (ten
publications); dyspnoea was not the reason for con-
sultation (52 publications); missing outcome (one
publication); full texts not available or other language
than English or German (17 studies).
Included studies
Apart from a study by Charles et al., which was per-
formed in Australia, all studies originate from European
countries. The publication time ranges from 2002 to
2012. The studies included patients of every age group,
mostly with a slightly female surplus. All studies re-
cruited data at general practices; recruitment duration
was 11.5 to 120 months. The study by Charles et al. ex-
tracted data out of a database in a retrospective way; all
other studies showed prospective patient recruitment.
Half of the studies were primarily performed to answer a
symptom evaluating research question. In contrast, the
studies from Burri and Nielsen et al. mainly evaluated
diagnostic tests for diagnostic decision making of dys-
pnoea while the symptom evaluation data derive from a
secondary analysis. Further details of the included stud-
ies are shown in Table 1.
Prevalence of “dyspnoea” in general practice
We extracted prevalence data out of three studies refer-
ring to 9 051 dyspnoea cases and 760 215 consultations.
The prevalence of dyspnoea in general practice ranges
from 0.87 to 2.59 % (Table 2). The database study by
Charles et al. reports a prevalence of 0.87 % (CI 0.85–
0.89) and the non-database studies from Frese and
Okkes et al. found a prevalence of 1.05 % (CI 0.85–1.29)
and 2.59 % (2.43–.2.59). Due to the low number of stud-
ies, we performed no a meta-analysis. Please see Table 2
for further details.
Aetiologies of “dyspnoea” in general practice
All six included studies provided data about the underlying
aetiologies of dyspnoea. The authors described a broad
spectrum of differential diagnoses which were summarized
in twelve categories, see Table 3. The presented diagnoses
show a high heterogeneity which was confirmed by both
heterogeneity sizes (I2 and tau2). Therefore we omitted
meta-analysis. Merely the analysis of the diagnostic cat-
egory “pneumonia” turns out with high homogeneity (I2
and tau2 = 0) enabling meta-analysis: The probability for
pneumonia as an underlying reason for dyspnoea at pri-
mary care setting is 2.7 % (CI 2.2–3.3).
Prognosis of “dyspnoea” in general practice
Two studies reported prognostic outcome parameters.
Burri et al. documented 94 hospitalizations and 20 case
of death among 323 patient during a one year follow-up
[10]. In addition, a symptom evaluation after three
month was done showing 32 % of the respective patients
to be symptom free [10]. Nielsen et al. assessed the mor-
tality rates and the symptom status among 269 dyspnoea
patients during a six month follow-up [13]: 58 % of the
patients reported symptom improvement, 34 % experi-
enced no change and 5 % showed worsening; 3 % were
dead (all reasons).
Quality of included studies
Regarding to domain A (selection of patients and GPs),
risk of bias of most included studies (5/6) was classified
as unclear, because quality assessment criteria regarding
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Table 1 Brief description of the included studies
Studies Recruitment
duration [month]






Inclusion criteria Exclusion criteria Answered
research
questions






53.9 prospective - all patients presented with
dyspnoea as their primary
symptom
- < 18 years 2b + 3c
- obvious traumatic cause
of dyspnoea
- Dyspnoea had to be of new
onset or clearly worsening if
preexisting
- severe renal disease
[defined by a serum
creatinine level of more





72 Australien 6021 general
practitioners
<5 years: 3.0 % 53.2 retrospective - all documented patients
with shortness of breath
— 1a + 2b
5–14 years: 3.3 %
15–24 years: 4.6 %
25–44 years:10.8 %
45–64 years: 21.2 %
65–74 years: 21.7 %
75+ years: 35.3 %
Frese, 2011
(SESAM Study)





56.9 prospective - all patients with a direct (face
to face) GP contact; independent
from consultation reason
none 1a + 2b
Median age:
55 years




47.7 prospective - all patients with dyspnoea
of at least 2 weeks duration
- patients with dyspnoea of at
least less 2 weeks duration
2b + 3c




49.0 prospective - all patients with dyspnoea
of at least 2 weeks duration
- patients with dyspnoea of at
least less 2 weeks duration
2b




— 56.5 prospective - all patients with a direct (face
to face) GP contact; independent
from consultation reason




aFirst research question: Prevalence of the consulting reason dyspnoea at general practice
bSecond research question: Aetiology of the consulting reason dyspnoea at general practice
cThird research question: Prognosis of the consulting reason dyspnoea at general practice












to selection of patients and GPs were not adequately
described. In the study of Burri et al., the risk that
the selection of patients introduced bias was judged
as low. All included studies showed a low risk that
the mode of data collection and/or patients flow in-
troduced bias (domain B). Quality assessment for the
determination of the underlying aetiology of the
symptom (domain C) was done for every diagnostic
category of each study. The two studies from Nielsen
et al. had the lowest risk that the diagnostic work up
introduce bias. In contrast, the three studies from
Charles et al. Frese et al. and Okkes et al. showed a
predominantly high risk that the diagnostic work up
introduce bias. Regarding to the determination of
prognosis (domain D), the two studies containing
prognostic information contain a high risk for bias.
The detailed results of the quality assessment are de-
scribed at Table 4.
Discussion
Main findings
This systematic review identified 6 symptom evaluat-
ing studies on dyspnoea in the primary care setting.
The prevalence of dyspnoea as reason for consultation
ranges from 0.87 to 2.59 % in general practice.
Among all dyspnoea patients 2.7 % (CI 2.2–3.3) suffer
from pneumonia. Further specification of underlying
aetiologies seems difficult due to the studies hetero-
geneity showing a great variety of probabilities.
Interpretation of findings in relation to previously
published work
In contrast to secondary care setting (dyspnoea preva-
lence at emergency departments: 7.4 % [2]), we found
rather low prevalences of dyspnoea ranging from 0.87 to
2.59 % at primary care setting. The Transitions Project,
provided in the article from Frese et al., showed a higher
prevalence value compared to the two other studies.
This can be explained by the different formations of
the underlying study populations (denominator of the
prevalence ratio). At BEACH- and SESAM project,
the prevalence ratio was calculated by division of the
number of dyspnoea patients (counter) through all
direct encounters during assessment time (without
double consultations) (denominator). In contrast, at
Transition project the prevalence value was calculated
by the number of dyspnoea patients (counter) through
all active listed patients (denominator).
With exception of the diagnostic category “pneumo-
nia”, the results of the different studies show high
heterogeneity. The study by Charles et al. seems to
differ from all other studies with respect to the distri-
bution of underlying aetiologies [11]. Again this pos-
sibly refers to the chosen study design. Charles’s
study refers to a retrospective primary care register.
Possibly in this underlying chronic diseases of dys-
pnea were documented more frequently than acute
illnesses (e.g. a simple respiratory infection), because
documentation of chronic diseases are more relevant
concerning long term care and possibly reimburse-
ment. In contrast, the prospective studies from Okkes
and Frese showed a higher rate of respiratory infec-
tions [12, 15], where recruitment of dyspnea patients
was done in a consecutive way.
Furthermore, there are large differences between
the studies regarding the diagnostic categories
“COPD/chronic bronchitis”, “asthma/allergy” and
“heart failure”. This is most likely based on the dif-
ferent age distribution of the study populations and
different diagnostic strategies. In fact the study by
Burri et al., had a special focus on the diagnosis of
heart failure and the average age of the studies’
population was higher compared to the other studies’
participants [10].
All studies of the review have included patients with
dyspnea independent from duration and severity of the
symptom which might result in differences in the pro-
portionately composition between acute and chronic
dyspnoea cases among the study populations. Even
Table 2 Prevalence
Number of patients with the
consultation reason dyspnoeaa
Overall consultations Prevalence CI
Charles, 2005 (BEACH Program) 5215 602100 b 0.87 % 0.85–0.89
Frese, 2011 (SESAM Study) 93 8877 b 1.05 % 0.85–1.29
Okkes, 2002 3743 149238 c 2.59 % 2.43–2.59
Frese, 2011 (Transition Project d)
aPatients with several consultations were singular counted during assessment time
bAll direct encounters during assessment time (without double consultations)
cAll active listed patients
dBoth studies from Frese and Okkes published data from the Transitions Project persist. Due to the more detailed data presentation, we extracted the data from
the article from Frese et al
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Table 3 Aetiologies of the symptom “dyspnoea” in general practice


















— 587 37 — — 1498 3.7–79.0 1.3146 99.8 % <0.0001 —
11.3 % 39.8 % 40.1 %
10.5–12.2 29.9–50.5 38.5–41.6
Pneumonia 11 — 3 — — 99 2.7–2.7 0 0 % 0.6907 2.7 [2.2–3.3]
3.4 % 3.2 % 2.6 %
1.8–6.2 0.8–9.8 2.2–3.2
COPD / chronic bronchitis 94 998 9 — — 112 1.3–58.6 1.3833 99.3 % <0.0001 —
29.1 % 19.2 % 9.7 % 3.0 %
24.3–34.4 18.1–20.3 4.8–18.0 2.5–3.6
Asthma / Allergy — 1092 5 — — 431 4.9–28.6 0.2632 98.6 % <0.0001 —




— — — — — 18 — — — — —
0.5 %
0.3–0.8
Heart failure 115 946 6 — — 153 1.6–54.8 1.1580 99.3 % <0.0001 —
35.6 % 18.2 % 6.5 % 4.1 %
30.4–41.1 17.2–19.3 2.7–14.1 3.5–4.8
Other cardiovascular diseases — 650 9 — 20 79 0.6–40.6 1.3523 98.8 % <0.0001 —
12.5 % 9.7 % 5.8 % 2.1 %
11.6-13.4 4.8–18.0 3.7–9.0 1.7–2.6
Psychosomatic cause 13 177 1 — 2 314 0.9–12.3 0.4524 96.5 % <0.0001 —
4.0 % 3.4 % 1.1 % 0.1 % 8.4 %
2.3-7.0 2.9–3.9 0.06–6.7 0.1–2.3 7.5–9.3
Musculoskeletal cause — — 2 — — 3 0.0–26.9 5.0575 92.3 % 0.0003 —
2.2 % 0.1 %
0.4-8.3 0.02–0.3
Obesity Lack of fitness 29 — 1 — 31 5 0.1–31.9 2.3909 96.6 % <0.0001 —
9.0 % 1.1 % 9.0 % 0.1 %
6.2-12.8 0.06–6.7 6.3–12.6 0.05–0.3












Table 3 Aetiologies of the symptom “dyspnoea” in general practice (Continued)
1.2 % 0.2 %
0.4-3.2 0.1–0.4
No diagnosis 61 447 12 42 62 529 7.0–26.3 0.1503 95.0 % <0.0001 —
18.9 % 8.6 % 12.9 % 14.8 % 18.0 % 14.1 %
14.9-23.7 7.9–9.4 7.1–21.8 11.0–19.6 14.2–22.5 13.0–15.3
Other — a b c d e
a-Diagnoses in 303 cases (5.8 %, CI 5.2–6.5) are not listed at article
b-Sleep disorder: 1 (1.1 %, CI 0.06–6.7)
-Prevention/no disease 2 (2.2 %, CI 0.4–8.3)
-Diagnoses in 5 cases (5.4 %, CI 2.0–12.7) are not listed at article
c-Heart failure (systolic dysfunction, diastolic dysfunction, atrial fibrillation, valvular disease, secondary pulmonary hypertension): 48 (16.9 %, CI 12.8–21.9)
-Lung disease (COPD, asthma, α-1 antitrypsin deficiency, restrictive lung disease, thoracic deformities, lung cancer, stenosis trachea): 100 (35.2 %, CI 29.7–41.1)
-Combined heart and lung disease:40 (14.1 %, CI 10.4–18.8)
-Other well defined reason: 54 (14.1 %, CI 10.4–18.8)
d-Heart failure (systolic dysfunction, diastolic dysfunction, atrial fibrillation, valvular disease, secondary pulmonary hypertension): 51 (14.8 %, CI 11.3–19.1)
-Lung disease (COPD, asthma, α-1 antitrypsin deficiency, restrictive lung disease, thoracic deformities, lung cancer, stenosis trachea): 136 (39.4 %, CI 34.3–44.8)
-Combined heart and lung disease: 30 (8.7 % CI 6.1–12.3)
-Angina pectoris: 20 (5.8 CI 3.7–4.0)
-Neurologic origin: 2 (0.6 % CI 0.1–2.3)
-Hypertension: 2 (0.6 % CI 0.1–2.3)
-Paroxysmal tachycardia: 1 (0.3, CI 0.02–1.9)
-Intrathoracic goiter: 1 (0.3, CI 0.02–1.9)
-Allergy: 1 (0.3, CI 0.02–1.9)
-Side effect from medication: 1 (0.3, CI 0.02–1.9)
-Malignant disease:1 (0.3, CI 0.02–1.9)
e-Prevention/no disease 56 (1.5 %, CI 1.2–2.0)
-Diagnoses in 441 cases (11.8 %, CI 10.8–12.9) are not listed at article












Table 4 Methodical quality of the included studies
Burri et al. Charles et al. Frese et al. Nielsen et al. (2001) Nielsen et al. (2004) Okkes et al.
Domain A: Selection of patients and GPs (refers to all studies regardless the review question)
Was the symptom to be investigated clearly described? no no no no no no
Were the selection criteria of the patients clearly described? yes yes yes unclear unclear yes
Was a consecutive or random sample of patients enrolled? yes yes yes yes yes yes
Was it a multi-centre study? yes yes yes yes yes yes
Did the selection criteria of the patients permit the study population to represent the full spectrum
of those presenting with the symptom in the respective setting/ addressed in the review question?
yes unclear unclear yes no unclear
Were the participating health care professionals/ institutions representative for setting to be investigated
in the review?
yes yes yes yes yes yes
Concern that the selection of patients and GPs introduced substantial variation low low low unclear unclear low
Risk that the selection of patients introduced bias: low, unclear, high low unclear unclear unclear unclear unclear
Domain B: Data collection and patient flow (refers to all studies regardless of the review question)
Were data about the symptom und the inclusion criteria collected directly from the patients (as opposed
to a proxy like a register, routine documentation)?
yes yes yes yes yes yes
Was the same mode of data collection used for all patients? unclear yes yes yes yes yes
Was the number of non-responders/ dropouts unlikely to affect the results? yes unclear unclear yes yes unclear
Risk that the mode of data collection and/ or patient flow introduced bias: low, unclear, high low low low low low low
Domain C: Determination of the underlying aetiology of the symptom (refers only to review question “What are the underlying conditions and their respective frequencies (differential diagnosis)?”)













































Risk that the diagnostic work up introduce bias low (2/6) high (6/7) high (9/10) low (3/6) low (4/6) High (11/12)
unclear (2/6) a (1/7) a (1/10) Unclear (2/6) unclear (1/6) a (1/12)
a (1/6) a (1/6) a (1/6)
Domain D: Determination of the prognosis (refers only to review question “What is the prognosis of patients with the respective symptom presenting in the respective setting?”)
Was the prognostic outcome clearly defined? Yes (3/3) - - Yes (2/2) - -
Did the study design include a comparison group without the symptom? No (3/3) - - No (2/2) - -
Was the work up/ measurement likely to correctly classify the respective prognostic outcome? Yes (3/3) - - Yes (2/2) - -
Did every patient receive the same work up/ mode of data collection to verify the respective prognostic
outcome?
Yes (3/3) - - Yes (2/2) - -
Risk that the prognostic work up introduce bias High (3/3) - - High (2/2) - -












though we have no evidence from this review one would
expect that chronic dyspnea is mainly related to diseases
like heart failure, chronic bronchitis etc. whereas acute
dyspnoea is most likely associated with pneumonia, viral
infections or pulmonary embolism. This might be even
add to the different distribution of the diagnostic
categories.
In general, most diagnoses analyzed in the included
studies are based on clinical non standardized criteria
with great variety between studies. This leads to sub-
stantial blurring in the estimated probabilities. In
comparison to other symptoms (like abdominal pain
or dizziness), the proportion of unexplained com-
plaints (category “no diagnosis”) is rather rare among
dyspnea patients [16, 17]. GPs seem to have hypoth-
eses concerning the underlying aetiology; although
only 39 % of these turn out to be correct [13]. Niel-
sen et al. showed improvement of GP’s aetiological
appraisal when providing diagnostic work up in a
hospital. Nielsen reported that GPs tend to overdiag-
nose heart failure (overdiagnosed: 63 %; missed:
39 %). Diagnosis of pulmonary disease showed equi-
poise of overdiagnosis and missing (overdiagnosed:
50 %; missed 57 %) [13]. At present, there are no
primary care decision rules for the evaluation of
dyspnea.
Strengths and limitations of this study
Systematic reviews of symptom-evaluating studies
underlie four factors which could bias the effect size
of this systematic review from the real effect size
[18]: (i) Factors which influence the internal validity
of the included studies, like incomplete recruitment
or imprecise inclusion criteria; (ii) Factors which
might influence the external validity of the included
studies, like setting or recruitment characteristics
which impede transferability to the local health care
system; (iii) Factors which influence the internal val-
idity of our systematic review based on our own
methodology; (iiii) Factors influencing the external
validity of the review. We therefore followed a trans-
parent and standardized protocol for the quality as-
sessment of the included studies. The screening
process was done by two independent reviewers and
we defined clear inclusion criteria for the included
studies.
There are few publications which describe quality
criteria for prevalence studies [19, 20]: Hoy et al. de-
fined a 10-item risk of bias tool for prevalence stud-
ies and tested its interrater-reliability [19] and the
Evidence-Based Medicine Working Group from Rich-
ardson et al. developed criteria to evaluate articles
on disease probability for differential diagnosis [20].
These published criteria only comment on the quality
of prevalence studies. We developed a more compre-
hensive catalogue of criteria based on an extensive lit-
erature review and the Standards for the Reporting of
Diagnostic Accuracy (STARD) statement on diagnostic
accuracy studies [18, 21]. According to our quality cri-
teria, quality of the included studies shows a broad
spectrum from low to high risk of bias.
A search update (28/08/2015) identified 649 new
references since May 2012. After title and abstract
screening, 12 studies underwent full text analysis. Fi-
nally, one study fulfilled the inclusion criteria [22].
This study from Currow et al. was based on the same
database (BEACH Programm) like the already in-
cluded publication from Charles et al. and answered
the first (prevalence) and the second (aetiology) re-
search question. In comparison to analysis from
Charles at al., Currow et al. covered a longer recruit-
ment period (Charles: 6 years vs. Currow: 9 years)
and excluded persons under 18 years. Currow found
a prevalence of 0.96 % (95 %-CI: 0.93–0.99). The fol-
lowing percentage distributions of the underlying aeti-
ologies were described: chronic obstructive pulmonary
disease (10.4 %), asthma (9.6 %), heart failure (9.4 %),
hypertension (4.1 %), acute bronchitis/bronchiolitis
(4.0 %), ischaemic heart disease (3.0 %), sleep disturb-
ance (2.4 %) and anxiety (2.1 %). In summary, the re-
sults of the two publications are generally similar; the
existing differences are explainable due to the differ-
ent age-sample.
Implication for future research, policy and practice
Although, GPs need setting specific knowledge about
the pre-test probability (prevalence), the work-up
probability (suspected underlying aetiology), and the
impact of diagnostic testing (mainly generated from
patient history and clinical examination) in dyspnoea,
there are only few symptom evaluating studies published
to support their decision making. A comprehensive diag-
nostic study with sound methodology regarding recruit-
ment, standardized diagnosis, and follow up is needed in
order to gain empirical data for future guidelines and deci-
sion rules.
Conclusion
There is a great lack of empirical evidence on the preva-
lence, aetiology and prognosis of dyspnoea in general
practice. This might yield uncertainty in diagnosis and
evaluation of dyspnoea in primary care.
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